Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
The Colorado Marijuana Enforcement Division (MED), in collaboration with the state’s Department of Public Health & Environment (CDPHE), has issued a statewide recall of cannabis flower produced by RRSA, LLC. The recall was announced on November 7, 2025, following tests that revealed potentially unsafe levels of mold, yeast, and toxic heavy metals in a harvest batch grown outdoors in southern Colorado.
According to the MED, the recalled batch of cannabis flower failed state testing for total mold and yeast and “exceeded acceptable limits” for arsenic, cadmium, and lead. The affected product, a strain known as GG4 (also marketed as Gorilla Glue or Gorilla Glue #4), was sold between September 24 and November 5 at twenty dispensaries statewide, most located in the Denver metro area. Some dispensaries also sold the flower for medical use, while one affected location was identified in Colorado Springs.
The MED advises consumers to verify product packaging for growing license number 403R-01182, which identifies flower grown by RRSA, LLC. Products from this license holder should not be consumed.
Officials urge anyone who purchased cannabis flower from the affected batch to destroy it or return it to the dispensary of purchase for proper disposal. Those experiencing adverse reactions—such as respiratory issues, headaches, nausea, or other symptoms—should seek immediate medical attention and report the incident by filing a MED Reporting Form through the state’s official cannabis oversight system.
Mold and yeast contamination are among the most common causes of cannabis recalls, as exposure can pose health risks to individuals with weakened immune systems or chronic respiratory conditions. Heavy metals such as arsenic, cadmium, and lead, meanwhile, can accumulate in the body over time and contribute to serious long-term health effects.
This latest incident marks the twelfth cannabis recall in Colorado in 2025, signaling the increasing pressure on the state’s marijuana regulators to enhance safety monitoring and oversight. The recall follows the launch of a new surveillance testing program announced by the MED and CDPHE in October. Under this initiative, inspectors now conduct unannounced sampling of cannabis products from retail dispensaries statewide to test for contamination and verify label accuracy.
The data collected from this surveillance effort will be used to evaluate gaps in Colorado’s regulatory framework and guide improvements in public health standards for cannabis production and sales.
The RRSA recall highlights the critical importance of traceability, testing transparency, and verified compliance within the cannabis supply chain. As product safety becomes a growing public concern, operators across the industry are under increasing scrutiny to ensure that their cultivation and testing processes meet regulatory and ethical standards.
Platforms like Qredible’s Q-Verify™ and MyCOA® enable cultivators, manufacturers, and dispensaries to maintain blockchain-secured Certificates of Analysis (COAs), automate testing verification, and provide consumers with digital proof of compliance. By integrating transparent verification systems, businesses can reduce the risk of recalls, protect public health, and build long-term consumer trust.
With recalls increasing nationwide, cannabis operators must prioritize continuous compliance and proactive product validation. A single recall can disrupt operations, damage credibility, and expose businesses to legal risk. Transparent documentation and third-party verification are no longer optional—they are the foundation of sustainable growth in regulated industries.
To learn how verified compliance systems can help prevent product safety risks and enhance operational integrity, connect with our team.
